Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-12

Clinical Trial Update: Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

View source ↗

Summary

This update describes a clinical trial examining changes in nerve conduction properties in IVIg-dependent neuropathies, including Guillain-Barré syndrome, chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of Cologne | Conditions: Guillain-Barre Syndrome, CIDP | Status: UNKNOWN